M Künkel

2.7k total citations · 1 hit paper
27 papers, 2.0k citations indexed

About

M Künkel is a scholar working on Infectious Diseases, Pharmacology and Clinical Biochemistry. According to data from OpenAlex, M Künkel has authored 27 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 6 papers in Pharmacology and 5 papers in Clinical Biochemistry. Recurrent topics in M Künkel's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Bacterial Identification and Susceptibility Testing (5 papers). M Künkel is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Bacterial Identification and Susceptibility Testing (5 papers). M Künkel collaborates with scholars based in United States, Germany and United Kingdom. M Künkel's co-authors include Marin H. Kollef, Andrew F. Shorr, Alice Baruch, Paul B. Iannini, John S. Bradley, Donald R. Graham, J. R. Dalovisio, R. Brooks Gainer, Susan J. Rehm and Robert W. Yancey and has published in prestigious journals such as New England Journal of Medicine, Clinical Infectious Diseases and CHEST Journal.

In The Last Decade

M Künkel

27 papers receiving 1.9k citations

Hit Papers

Linezolid in Methicillin-... 2012 2026 2016 2021 2012 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study
    2012 402 citations Richard G. Wunderink, Michael S. Niederman et al. Clinical Infectious Diseases profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
M Künkel 1.1k 606 563 519 368 27 2.0k
Joel Ruskin 609 0.5× 257 0.4× 994 1.8× 266 0.5× 406 1.1× 32 2.2k
İftihar Köksal 1.3k 1.1× 256 0.4× 820 1.5× 147 0.3× 92 0.3× 139 2.5k
Mark R. Eckman 519 0.5× 181 0.3× 435 0.8× 253 0.5× 181 0.5× 13 1.4k
Hyunjoo Pai 648 0.6× 434 0.7× 1.1k 1.9× 225 0.4× 154 0.4× 116 2.6k
Denis W. Spelman 480 0.4× 191 0.3× 534 0.9× 212 0.4× 229 0.6× 80 2.2k
Marisa A. Montecalvo 1.6k 1.4× 86 0.1× 698 1.2× 743 1.4× 159 0.4× 40 2.5k
C C Kibbler 1.3k 1.1× 97 0.2× 948 1.7× 285 0.5× 107 0.3× 40 2.2k
Abraham Borer 523 0.5× 269 0.4× 806 1.4× 369 0.7× 73 0.2× 93 2.1k
Yee Gyung Kwak 550 0.5× 149 0.2× 518 0.9× 193 0.4× 133 0.4× 118 1.7k
John Segreti 788 0.7× 416 0.7× 891 1.6× 384 0.7× 51 0.1× 62 2.0k

Countries citing papers authored by M Künkel

Since Specialization
Citations

This map shows the geographic impact of M Künkel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Künkel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Künkel more than expected).

Fields of papers citing papers by M Künkel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Künkel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Künkel. The network helps show where M Künkel may publish in the future.

Co-authorship network of co-authors of M Künkel

This figure shows the co-authorship network connecting the top 25 collaborators of M Künkel. A scholar is included among the top collaborators of M Künkel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Künkel. M Künkel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wunderink, Richard G., Michael S. Niederman, Marin H. Kollef, et al.. (2012). Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study. Clinical Infectious Diseases. 54(5). 621–629. 402 indexed citations breakdown →
2.
Alemayehu, Demissie, John P. Quinn, Jack Cook, M Künkel, & Charles Knirsch. (2012). A Paradigm Shift in Drug Development for Treatment of Rare Multidrug-Resistant Gram-Negative Pathogens. Clinical Infectious Diseases. 55(4). 562–567. 18 indexed citations
3.
Itani, Kamal M.F., Matthew Dryden, Helen Bhattacharyya, et al.. (2010). Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus. The American Journal of Surgery. 199(6). 804–816. 119 indexed citations
4.
Wilcox, Mark H., M Künkel, & Charles Knirsch. (2009). Reply to Drekonja and to Lustberg et al.. Clinical Infectious Diseases. 49(2). 314–315. 2 indexed citations
5.
Wilcox, Mark H., Kenneth J. Tack, Emilio Bouza, et al.. (2008). Complicated Skin and Skin‐Structure Infections and Catheter‐Related Bloodstream Infections: Noninferiority of Linezolid in a Phase 3 Study. Clinical Infectious Diseases. 48(2). 203–212. 179 indexed citations
6.
Shorr, Andrew F., M Künkel, & Marin H. Kollef. (2005). Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies. Journal of Antimicrobial Chemotherapy. 56(5). 923–929. 165 indexed citations
7.
Tice, Alan D., Susan J. Rehm, J. R. Dalovisio, et al.. (2004). Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy. Clinical Infectious Diseases. 38(12). 1651–1671. 428 indexed citations
8.
Tice, Alan D., Susan J. Rehm, J. R. Dalovisio, et al.. (2004). Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy. Journal of Infusion Nursing. 27(5). 338–359. 28 indexed citations
9.
Brown, Richard B., Paul B. Iannini, Peter Groß, & M Künkel. (2003). Impact of Initial Antibiotic Choice on Clinical Outcomes in Community-Acquired Pneumonia. CHEST Journal. 123(5). 1503–1511. 97 indexed citations
10.
Sigal, Leonard H., John M. Zahradnik, Philip T. Lavin, et al.. (1998). A Vaccine Consisting of RecombinantBorrelia burgdorferiOuter-Surface Protein A to Prevent Lyme Disease. New England Journal of Medicine. 339(4). 216–222. 283 indexed citations
11.
Künkel, M. (1998). QUALITY ASSURANCE AND OUTCOMES IN OUTPATIENT PARENTERAL ANTIBIOTIC THERAPY. Infectious Disease Clinics of North America. 12(4). 1023–1034. 12 indexed citations
12.
Dattwyler, Raymond J., Benjamin J. Luft, M Künkel, et al.. (1997). Ceftriaxone Compared with Doxycycline for the Treatment of Acute Disseminated Lyme Disease. New England Journal of Medicine. 337(5). 289–295. 122 indexed citations
13.
Künkel, M. (1993). Quality Assurance. Hospital Practice. 28(sup1). 33–38. 15 indexed citations
14.
Künkel, M, et al.. (1990). [Long-term results following percutaneous reanastomosis of complete ureteral occlusion].. PubMed. 29(6). 321–4. 1 indexed citations
15.
Sträube, E., et al.. (1986). Epstein-Barr virus-specific immunoglobulin A in patients with infectious mononucleosis, an age-dependent factor. European Journal of Clinical Microbiology & Infectious Diseases. 5(2). 173–174. 5 indexed citations
16.
Iannini, Paul B., et al.. (1985). Imipenem/cilastatin: general experience in a community hospital. The American Journal of Medicine. 78(6). 122–126. 8 indexed citations
17.
Künkel, M & Paul B. Iannini. (1984). Cefonicid in a Once-Daily Regimen for Treatment of Osteomyelitis in an Ambulatory Setting. Clinical Infectious Diseases. 6(Supplement_4). S865–S869. 24 indexed citations
18.
Nowak, Radosław P., et al.. (1983). Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.. PubMed. 27(3). 277–81. 3 indexed citations
19.
Iannini, Paul B. & M Künkel. (1982). Cefotaxime failure in group A streptococcal meningitis.. PubMed. 248(15). 1878–1878. 16 indexed citations
20.
Hattersley, Paul G. & M Künkel. (1976). Cryoprecipitates as a Source of Fibrinogen in Treatment of Disseminated Introvascular Coagulation (DIC). Transfusion. 16(6). 641–645. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joel Ruskin Breakdown of academic impact, for papers by İftihar Köksal Breakdown of academic impact, for papers by Mark R. Eckman Breakdown of academic impact, for papers by Hyunjoo Pai Breakdown of academic impact, for papers by Denis W. Spelman Breakdown of academic impact, for papers by Marisa A. Montecalvo Breakdown of academic impact, for papers by C C Kibbler Breakdown of academic impact, for papers by Abraham Borer Breakdown of academic impact, for papers by Yee Gyung Kwak Breakdown of academic impact, for papers by John Segreti
Rankless by CCL
2026